Volume 5, Issue 1 UPDATE-ERR™ Winter 2012
President's Message

Happy New Year to all of our friends and colleagues!

Med-ERRS had a busy 2011 and is looking forward to working with all of you in 2012.

We are excited to report on two areas of consultative services that we have been involved with lately.  The first is participation in Human Factors Studies from the safety standpoint.  This can apply to user testing of product labels, drug preparation instructions, drug delivery devices and patient instructions for use.  Med-ERRS participation in such studies can provide real-time feedback in order to maximize the results of the testing.

The second is providing educational and professional development programs for industry professionals. 
Such programs focus on medication error prevention and how Med-ERRS services can fit into an overall plan for favorable safety and regulatory outcomes.

We welcome the opportunity to discuss these services on an individual basis and can work collaboratively with you on tailoring our safety services to fit your needs.

Med-ERRS has instituted a slight cost increase for 2012 (the first one in three years!).  Please contact us for an updated schedule of services and prices.

Best Wishes for a Prosperous 2012.


Recently Released FDA Guidances

Applying Human Factors and Usability Engineering to Optimize Medical Device Design

Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling

FDA Issues Draft Guidance on Biosimilar Product Development

Upcoming meetings that Med-ERRS will be attending

PTMG in Brussels, Belgium--March 19-20, 2012

INTA in Washington, DC--May 5-9, 2012

Hope to see you there!
In the News

Mix-ups between Amaryl and Almarl result in name change in Japan

FDA Completes Work on Three Drug User Fee Programs

FDA Approves Hydromorphone Labeling Revisions to Reduce Medication Errors

Ask an Expert

If you have a question related to on e of Med-ERRS services or have an industry-specific inquiry, please Click Here and one of our experts will get back to you with an answer.


Med-ERRS Services

  • Trademark Evaluation : Med-ERRS has developed a service for evaluating the safety of trademarks called the ERRS MODEL ® , which incorporates various techniques recommended by the FDA to evaluate the safety of trademarks.
  • SCREEN-ERR : Helps companies evaluate multiple pharmaceutical trademark candidates at an early stage in the trademark development process.
  • Package and Label Evaluation : Helps clients create packaging and labels that are easy to understand and consistent with the most current FDA and world wide regulatory authorities.
  • Safety Consulting : Provides consultative services which are related to a variety of medication safety-related issues.


200 Lakeside Dr, Suite 200
Horsham, PA 19044